GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 80027310326

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80027310326 and manufactured by BIOTECNICA INDUSTRIA E COMERCIO LTDA. The registration is held by BIOTECNICA INDUSTRIA E COMERCIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80027310326
Registration Details
ANVISA Registration Number: 80027310326
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

FamĂ­lia HbA1c Aut Plus
Risk Class II

Registration Details

80027310326

25351131525202331

02534069000120

Company Information

Brazil
PT: BRASIL

Dates and Status

Mar 27, 2023

VIGENTE

09/18/2025 19:00:01